Introduction
============

Superior segmental optic hypoplasia (SSOH) is a congenital optic nerve anomaly characterized by localized inferior visual field defects, superior nerve fiber layer defects, and good visual acuity.[@b1-opth-4-1193]--[@b13-opth-4-1193] The term "superior segmental optic nerve hypoplasia" (SSONH), which is preferred by some investigators, has also sometimes been used instead of SSOH, because the clinical features of this entity include not only a morphologic optic disc anomaly, but also optic nerve fiber defects.[@b10-opth-4-1193],[@b12-opth-4-1193] SSOH is considered to be a type of optic nerve hypoplasia, but is unusual in that the central visual acuity is spared. Kim et al have shown four characteristic findings concerning the optic disc, ie, a relative superior entrance of the central retinal artery, a superior peripapillary scleral halo, pallor of the superior disc, and a thinning of the superior peripapillary nerve fiber layer.[@b4-opth-4-1193] However, not all of these features could be consistently found in other reports.[@b6-opth-4-1193],[@b8-opth-4-1193]--[@b10-opth-4-1193] Instead, a double-ring sign, which is a hallmark of optic hypoplasia, has been found.[@b10-opth-4-1193] Also, while previous reports from Western countries have demonstrated that SSOH is frequently associated with maternal type 1 diabetes mellitus, reports from Japan and Korea have not supported this association.[@b10-opth-4-1193],[@b12-opth-4-1193] Thus, the definition of SSOH remains obscure, and it may possibly consist of multiple optic nerve anomalies.

The Heidelberg retina tomograph (HRT), a confocal scanning laser ophthalmoscopy device, has been used to evaluate quantitatively the three-dimensional surface topography of the optic nerve head and the surrounding nerve fiber layer.[@b14-opth-4-1193]--[@b26-opth-4-1193] HRT can provide objective measurements of the optic nerve head, such as the cup-to-disc ratio, cup volume, rim area, and thickness of the nerve fiber layer. It is well known that glaucomatous visual field defects appear only after a substantial number of nerve fibers have been lost.[@b27-opth-4-1193],[@b28-opth-4-1193] Therefore, HRT is considered to be a promising tool for the early detection of glaucoma. A thinning of the nerve fiber layer often suggests glaucoma, but SSOH is similar to glaucoma in that nerve fiber layer defects and corresponding visual field losses are observed.[@b8-opth-4-1193] In this study, we investigated the topography of the optic nerve head in SSOH using HRT. This technique includes statistical analyses, Frederick S Mikelberg (FSM) discriminant function,[@b14-opth-4-1193] Moorfields regression analysis (MRA),[@b16-opth-4-1193] and the glaucoma probability score (GPS) classification,[@b18-opth-4-1193] for discriminating glaucomatous and normal optic discs. We also used HRT to evaluate the diagnostic ability of these tests in patients with SSOH.

Subjects and methods
====================

We examined 13 eyes of 13 patients with SSOH. The mean age ± standard deviation of the patients was 34.7 ± 12.9 (range 15--53) years. There were six males and seven females. Seven had bilateral and six had monocular SSOH. Only one eye was randomly selected and examined for bilateral cases. Each eye had a best-corrected visual acuity ≥20/20 and a normal intraocular pressure (IOP) ≤21 mmHg, with no history of elevated IOP, a normal open angle, and an inferior wedge-shaped visual field defect (oriented to the blind spot) with a corresponding retinal nerve fiber layer defect. The retinal nerve fiber layer defects were detected with ophthalmoscopy and documented by fundus photographs. None of the patients was born of a mother with diabetes mellitus. The average mean deviation of the Humphrey full-threshold 30-2 program was −4.35 ± 4.37 (ranging from −11.96 to +1.76) dB. Thirteen eyes of 13 subjects with normal vision were also studied and served as controls. Only one eye was examined for each normal subject. The normal subjects were recruited from the hospital staff or their friends. Ophthalmic examination of these subjects did not reveal any ocular abnormalities.

In each patient, optic disc topography was examined using HRT II (version 3.0; Heidelberg Engineering, GmbH, Heidelberg, Germany). Informed consent was obtained from each subject. HRT II uses a diode laser (670 nm wavelength) to scan the retinal surface sequentially in the horizontal and vertical directions on multiple focal planes. By using confocal scanning principles, a three-dimensional topographic image is constructed from a series of optical image sections at consecutive focal planes. The topographic image determined from the acquired three-dimensional image consists of 384 × 384 (147,456) pixels, each of which is a measurement of the surface height of retina and optic nerve head at its corresponding location. For every subject in this study, images were obtained through undilated pupils, with a 15° field of view. Three topographic images were obtained, combined, and automatically aligned to make a single mean topographic image for analysis. A contour line of the optic disc margin was drawn around the inner margin of the peripapillary scleral ring by an experienced examiner, who had been kept uninformed of the other clinical information. Six HRT parameters obtained with routine analysis were analyzed in terms of the disc area, cup area, cup-to-disc area ratio, rim area, cup shape measure, and height variation contour. Magnification errors were corrected using the subjects' refractive status and corneal-curvature measurements.

Six sectoral (temporal, nasal, superotemporal, superonasal, inferotemporal, and inferonasal) and global optic nerve head parameters were compared between those of the control subjects and those of patients with SSOH, thus producing *P* values and the area under the curve (AUC for the receiver operating characteristic) for each comparison.

For the FSM discriminant function, the discriminant analysis formula described by Mikelberg et al was used.[@b14-opth-4-1193] We chose the FSM discriminant function because it was thought to be the most representative among such discriminant functions. In the MRA, a measured rim area was compared with the predicted rim area adjusted for disc size and age. The normative database was compared in six regions (superior temporal, inferior temporal, temporal, superior nasal, inferior nasal, and nasal) and as an overall global classification. The eyes were classified into three categories: within normal limits (WNL) 95% confidence intervals (CI); borderline (BL), 95%--99.9% CI; and outside normal limits (ONL), 99.9% CI. In the GPS calculation, parameters describing the shape of the optic nerve head and retinal nerve fiber layer were calculated based on the mathematical model derived from normal and glaucomatous eyes in HRT. The parameters thus obtained were used to compute the GPS numeric scores. Then, the final GPS was used for the classification was WNL (0%--27%), BL (28%--64%), and ONL (65%--100%). The AUC curves were plotted between the normal and SSOH eyes for the FSM discriminant function, MRA, and GPS. The categoric variable was computed where "normal" = 0, "borderline" = 1, and "outside normal limits" = 2.

We used Mann--Whitney's *U* test for each comparison. Because of the large number of tests, the Bonferroni correction for multiple comparisons was also applied. SPSS (17.0 J; SPSS Japan, Inc., Tokyo, Japan) and MedCalc (version 10.1; MedCalc Software bvba, Mariakerke, Belgium) were used to perform the statistical analysis.

Results
=======

[Table 1](#t1-opth-4-1193){ref-type="table"} shows the demographic and clinical characteristics of the subjects included in the study. Gender, age, and refraction did not differ significantly between the patients with SSOH and normal subjects. None of the patients with SSOH showed a progression of the visual field defects in the subsequent follow-up. The follow-up period was 74.4 ± 27.2 (range 48--133) months.

[Table 2](#t2-opth-4-1193){ref-type="table"} shows various HRT parameters of the patients with SSOH and the healthy control subjects. There was no statistically significant difference between the disc area of patients with SSOH and normal subjects. The cup area and cup-to-disc area ratio were larger, while the rim area was reduced, in patients with SSOH, especially in the superonasal area. The parameters with the largest AUCs were the nasal superior cup shape measure (0.988), the nasal superior cup-to-disc area ratio (0.970), and the nasal superior rim area (0.959). [Figure 1](#f1-opth-4-1193){ref-type="fig"} shows the AUC for the nasal superior cup shape measure.

The results of the diagnostic classification tests are shown in [Table 3](#t3-opth-4-1193){ref-type="table"}. Using the FSM discriminant function, 92.3% of the eyes were classified as outside the normal limits. By the MRA and GPS, 84.6 (\*76.9)% and 46.2% of the eyes were classified as abnormal, respectively (when the borderline was classified as normal). The MRA in each sector revealed that the superonasal rim area was most frequently abnormal ([Figure 2](#f2-opth-4-1193){ref-type="fig"}). The AUC was 0.976 for the FSM discriminant function, 0.914 for the MRA, and 0.710 for the GPS. The sectoral analysis of MRA revealed the largest AUC (0.956) in the nasal superior sector. The FSM discriminant function showed a sensitivity of 92.3% and a specificity of 92.3%. The MRA overall classification had a sensitivity of 84.6 (76.9)% and a specificity of 92.3 (100)%. The GPS overall classification had a sensitivity of 46.2 (46.2)% and a specificity of 92.3 (100)%.

Discussion
==========

Our sectorial analysis of the optic nerve head has shown that many of the parameters differed significantly between normal subjects and patients with SSOH. Also, a large proportion of the eyes with SSOH were determined to be abnormal using the FSM discriminant function and MRA. It is important to distinguish this condition from glaucoma, because costly antiglaucoma medication is not warranted in the presence of SSOH, assuming that SSOH is a nonprogressive disease. Whereas a notch in the inferotemporal or superotemporal rim is commonly found in glaucoma, the rim area in the superonasal segment was found by this study to be most decreased in cases of SSOH. Our results may be generalized to cases of SSOH in general, because it is thought to be a nonprogressive disease and the degree of disease severity is not so variable as in glaucoma.[@b21-opth-4-1193],[@b24-opth-4-1193] There may be "subclinical" SSOH in which visual field testing does not detect any abnormality, while, in fact, nerve fibers are already reduced. HRT could be helpful in such cases.

The definition of SSOH remains to be determined. So far, different studies have used different criteria to define SOOH. We used diagnostic criteria based on a previous report.[@b10-opth-4-1193] However, the appearances of the optic discs of SSOH in this study appear to be somewhat different from those reported in Western countries. In general, the optic discs of SSOH in Japan often have a glaucoma-like cupping.[@b7-opth-4-1193],[@b8-opth-4-1193],[@b10-opth-4-1193] Although glaucoma has to be excluded in the initial diagnosis of SSOH, because the former is an acquired optic nerve disorder, the association between SSOH and glaucoma remains unclear. It is sometimes difficult to differentiate SSOH from glaucoma (especially from normal- tension glaucoma, in which the IOP is within normal limits) because the two share similar optic disc appearance features, such as a large cupping and a rim thinning.[@b10-opth-4-1193] Furthermore, glaucoma and SSOH do coexist in some cases. However, optic discs in the case reports from Western countries do not seem to show any general glaucoma-like cupping.[@b11-opth-4-1193] Additionally, SSOH is almost never associated with maternal diabetes mellitus in Japan. Thus, SSOH may be heterogeneous, and our conclusion may apply only to the specific type of SSOH that is typically found in Japan or Korea. However, superior nerve fiber layer defects and corresponding inferior visual field defects (either inferior altitudinal defects or inferior sector defects connected to the blind spot) are always observed in SSOH.

The visual fields in SSOH are shown to be stable over a 10-year period[@b9-opth-4-1193] or an eight-year period,[@b10-opth-4-1193] but the long-term prognosis is not known, because no longer follow-ups have yet been reported. SSOH has been found in young patients, in whom glaucoma is less likely than in aged patients.[@b10-opth-4-1193] These findings seem to support the notion that SSOH is a congenital anomaly and does not progress. HRT could be used for the patients with SSOH over time to make sure that there is no progression of the disease.

Subjective qualitative techniques, such as ophthalmoscopy, are dependent on the examiner's experience. However, only a few previous reports investigating SSOH have utilized objective quantitative imaging technologies of the optic disc.[@b7-opth-4-1193],[@b10-opth-4-1193],[@b11-opth-4-1193] Unoki et al used OCT to investigate the tomography of the optic disc and peripapillary retina in patients with SSOH.[@b7-opth-4-1193] Using OCT, obviously abnormal findings may be observed in patients in whom the optic disc shows only minimal changes, even in the fundus photograph.[@b7-opth-4-1193] Although both OCT and HRT can provide objective quantitative measurements of optic disc topography, the fundamental measurement principles of these two instruments are different. HRT is thought to be specifically useful for accurate structural assessments of the optic nerve head.[@b16-opth-4-1193],[@b19-opth-4-1193] A recent study utilizing OCT and HRT in SSOH generally supports our findings.[@b13-opth-4-1193]

In this study, most eyes with SSOH were classified as abnormal, with a high specificity, using the FSM discriminant function and MRA. HRT generally requires a manual drawing of the contour line of the edge of the optic disc,[@b16-opth-4-1193],[@b19-opth-4-1193] and this process introduces an element of uncontrolled variability into the analysis because such contour lines, drawn by different observers, may vary considerably. The outlining of the disc margin is not necessary for GPS, and thus GPS is considered to be a more objective method than MRA.[@b18-opth-4-1193] While sensitivity and specificity values were found to be comparable between MRA and GPS in some reports,[@b20-opth-4-1193] the agreement between MRA and GPS is not necessarily high in defining glaucoma in other reports.[@b22-opth-4-1193] This study also shows that such an agreement is not high in SSOH either, probably reflecting the differences in the analysis algorithm. It is not surprising to find a rather low sensitivity for the GPS, because this is a diagnostic test designed specifically for glaucoma,[@b18-opth-4-1193] but not for SSOH. Alternatively, the GPS results in this study may have revealed that the GPS is not sensitive to the local rim-volume losses, which are shown by MRA, because of the influence of neighboring normal sectors.[@b20-opth-4-1193] Therefore, sectorial HRT-GPS analysis appears to have some limitations, although it has the clear merit that it is independent of the contour line traced manually by an examiner. Although it has been reported that both GPS and MRA are likely to produce many false-positive classifications in glaucoma,[@b20-opth-4-1193] high specificity values were obtained in SSOH. It has been reported that optic disc size influences the diagnostic accuracy of HRT in glaucoma, with small optic discs showing a lower sensitivity and a higher specificity compared with larger discs.[@b24-opth-4-1193] In this study, the disc area in SSOH was not statistically significantly different from that of the controls.

Since diagnostic tests for glaucoma using HRT frequently determine the SSOH to be abnormal, it will be necessary in a future study to develop a test which can reliably differentiate SSOH from glaucoma. From our results, it seems that HRT can discern the pattern of the area of rim losses between SSOH and glaucoma. Our results also indicate that HRT can be useful in identifying a reduction of the rim area, especially in the superonasal region, in patients with SSOH.
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###### 

Demographic and clinical characteristics of the subjects included in the study

                                                       SSOH (N = 13)[\*](#tfn1-opth-4-1193){ref-type="table-fn"}   Normal (N = 13)[\*](#tfn1-opth-4-1193){ref-type="table-fn"}   *P* value[†](#tfn2-opth-4-1193){ref-type="table-fn"}
  ---------------------------------------------------- ----------------------------------------------------------- ------------------------------------------------------------- ------------------------------------------------------
  Sex (M/F)                                            6/7                                                         4/9                                                           0.420
  Age (years)                                          34.7 ± 12.9 (15,53)                                         34.6 ± 9.1 (22,55)                                            0.840
  Refraction (diopters)                                −3.71 ± 3.31 (−10.00, −0.50)                                −3.58 ± 1.92 (−7.25, −1.13)                                   0.614
  MD (dB)[‡](#tfn3-opth-4-1193){ref-type="table-fn"}   −4.35 ± 4.37 (−11.96, +1.76)                                1.26 ± 1.04 (−0.88, +2.92)                                    \<0.001

**Notes:** Data are presented as mean ± standard deviation (range);

*P* value is for comparison between SSOH and normal eyes using Mann--Whitney's *U* test;

mean deviation of Humphrey 30-2 visual field.

**Abbreviations:** SSOH, superior segmental optic hypoplasia; M, male; F, female; MD, mean deviation.

###### 

Global and segmental optic disc parameters and areas under the receiver operating characteristic curve for each parameter

                  SSOH (N = 13)[\*](#tfn5-opth-4-1193){ref-type="table-fn"}   Normal (N = 13)[\*](#tfn5-opth-4-1193){ref-type="table-fn"}   *P* value     AUC[‡](#tfn7-opth-4-1193){ref-type="table-fn"}
  --------------- ----------------------------------------------------------- ------------------------------------------------------------- ------------- ------------------------------------------------
  DA global       1.97 ± 0.55 (1.18--3.17)                                    2.05 ± 0.47 (1.12--2.86)                                      0.650         0.556 (0.350--0.749)
  DA temporal     0.48 ± 0.15 (0.24--0.81)                                    0.47 ± 0.11 (0.25--0.63)                                      0.920         0.515 (0.313--0.714)
  DA TS           0.26 ± 0.05 (0.19--0.36)                                    0.29 ± 0.07 (0.18--0.43)                                      0.243         0.636 (0.426--0.814)
  DA TI           0.25 ± 0.07 (0.15--0.40)                                    0.28 ± 0.08 (0.15--0.45)                                      0.287         0.624 (0.414--0.804)
  DA nasal        0.47 ± 0.15 (0.24--0.79)                                    0.48 ± 0.12 (0.24--0.64)                                      0.801         0.533 (0.328--0.729)
  DA NS           0.25 ± 0.08 (0.14--0.44)                                    0.26 ± 0.07 (0.13--0.39)                                      0.579         0.568 (0.361--0.759)
  DA NI           0.26 ± 0.06 (0.20--0.39)                                    0.27 ± 0.06 (0.18--0.37)                                      0.311         0.621 (0.411--0.802)
  CA global       0.93 ± 0.51 (0.29--1.98)                                    0.40 ± 0.22 (0.03--0.78)                                      0.007         0.805 (0.603--0.932)
  CA temporal     0.28 ± 0.16 (0.08--0.58)                                    0.19 ± 0.10 (0.02--0.32)                                      0.153         0.666 (0.455--0.837)
  CA TS           0.14 ± 0.06 (0.05--0.23)                                    0.06 ± 0.04 (0.00--0.11)                                      \<**0.001**   0.882 (0.694--0.973)
  CA TI           0.09 ± 0.07 (0.00--0.21)                                    0.04 ± 0.03 (0.00--0.09)                                      0.050         0.728 (0.519--0.882)
  CA nasal        0.21 ± 0.15 (0.00--0.54)                                    0.06 ± 0.05 (0.00--0.16)                                      0.003         0.831 (0.634--0.947)
  CA NS           0.15 ± 0.06 (0.02--0.28)                                    0.04 ± 0.03 (0.00--0.11)                                      \<**0.001**   0.932 (0.760--0.991)
  CA NI           0.07 ± 0.05 (0.00--0.15)                                    0.02 ± 0.01 (0.00--0.04)                                      0.002         0.843 (0.648--0.954)
  RA global       1.04 ± 0.18 (0.78--1.38)                                    1.66 ± 0.45 (1.03--2.53)                                      \<**0.001**   0.932 (0.760--0.991)
  RA temporal     0.20 ± 0.05 (0.09--0.30)                                    0.28 ± 0.11 (0.18--0.52)                                      0.019         0.769 (0.563--0.910)
  RA TS           0.12 ± 0.03 (0.07--0.18)                                    0.23 ± 0.07 (0.11--0.33)                                      \<**0.001**   0.926 (0.752--0.989)
  RA TI           0.16 ± 0.04 (0.09--0.25)                                    0.24 ± 0.08 (0.14--0.43)                                      0.002         0.843 (0.648--0.954)
  RA nasal        0.26 ± 0.08 (0.10--0.38)                                    0.42 ± 0.11 (0.21--0.62)                                      \<**0.001**   0.891 (0.706--0.977)
  RA NS           0.10 ± 0.03 (0.04--0.16)                                    0.22 ± 0.07 (0.13--0.33)                                      \<**0.001**   0.959 (0.799--0.994)
  RA NI           0.20 ± 0.05 (0.14--0.28)                                    0.26 ± 0.06 (0.18--0.37)                                      0.006         0.811 (0.610--0.935)
  CDAR global     0.45 ± 0.14 (0.23--0.66)                                    0.19 ± 0.10 (0.01--0.35)                                      \<**0.001**   0.926 (0.752--0.989)
  CDAR temporal   0.55 ± 0.19 (0.24--0.82)                                    0.40 ± 0.18 (0.06--0.63)                                      0.072         0.710 (0.500--0.869)
  CDAR TS         0.52 ± 0.15 (0.24--0.78)                                    0.21 ± 0.15 (0.01--0.47)                                      \<**0.001**   0.929 (0.756--0.990)
  CDAR TI         0.32 ± 0.21 (0.01--0.67)                                    0.14 ± 0.11 (0.00--0.27)                                      0.026         0.754 (0.547--0.900)
  CDAR nasal      0.41 ± 0.22 (0.00--0.68)                                    0.12 ± 0.10 (0.00--0.32)                                      **0.001**     0.861 (0.669--0.963)
  CDAR NS         0.58 ± 0.14 (0.17--0.74)                                    0.15 ± 0.12 (0.00--0.43)                                      \<**0.001**   0.970 (0.817--0.992)
  CDAR NI         0.24 ± 0.15 (0.00--0.48)                                    0.06 ± 0.06 (0.00--0.16)                                      **0.001**     0.855 (0.662--0.960)
  HVC             0.39 ± 0.13 (0.18--0.68)                                    0.41 ± 0.07 (0.27--0.52)                                      0.264         0.633 (0.423--0.811)
  HVC temporal    0.15 ± 0.06 (0.04--0.25)                                    0.20 ± 0.06 (0.12--0.34)                                      0.101         0.692 (0.482--0.856)
  HVC TS          0.16 ± 0.15 (0.02--0.48)                                    0.17 ± 0.06 (0.05--0.29)                                      0.186         0.654 (0.443--0.828)
  HVC TI          0.21 ± 0.08 (0.10--0.38)                                    0.23 ± 0.09 (0.09--0.38)                                      0.579         0.568 (0.361--0.759)
  HVC nasal       0.14 ± 0.07 (0.06--0.27)                                    0.11 ± 0.04 (0.06--0.23)                                      0.479         0.586 (0.378--0.774)
  HVC NS          0.09 ± 0.04 (0.03--0.18)                                    0.05 ± 0.02 (0.03--0.11)                                      0.019         0.769 (0.563--0.910)
  HVC NI          0.09 ± 0.05 (0.02--0.24)                                    0.07 ± 0.04 (0.02--0.15)                                      0.186         0.654 (0.443--0.828)
  CSM             −0.08 ± 0.10 (−0.28--0.11)                                  −0.21 ± 0.05 (−0.28, −0.10)                                   \<**0.001**   0.882 (0.694--0.973)
  CSM temporal    −0.07 ± 0.08 (−0.19--0.09)                                  −0.11 ± 0.06 (−0.22, −0.01)                                   0.113         0.686 (0.476--0.852)
  CSM TS          0.05 ± 0.09 (−0.08--0.25)                                   −0.14 ± 0.12 (−0.31--0.03)                                    \<**0.001**   0.905 (0.725--0.983)
  CSM TI          −0.07 ± 0.14 (−0.37--0.16)                                  −0.22 ± 0.10 (−0.39, −0.07)                                   0.006         0.811 (0.610--0.935)
  CSM nasal       −0.00 ± 0.15 (−0.25--0.30)                                  −0.18 ± 0.13 (−0.46, −0.02)                                   0.005         0.814 (0.613--0.937)
  CSM NS          0.15 ± 0.15 (−0.13--0.40)                                   −0.18 ± 0.08 (−0.33, −0.03)                                   \<**0.001**   0.988 (0.845--1.000)
  CSM NI          −0.10 ± 0.18 (−0.40--0.18)                                  −0.31 ± 0.15 (−0.55, --0.04)                                  0.006         0.808 (0.606--0.934)

**Notes:** Data are presented as mean ± standard deviation (range);

*P* value is for comparison of the parameters between SSOH and normal eyes using Mann--Whitney's *U* test. Because of the multiple comparisons, the Bonferroni correction was applied, with a level of significance of 0.00119. Bold *P* values are statistically significant.

Data are expressed with 95% confidence intervals of each value in parentheses.

**Abbreviations:** DA, disc area; CA, cup area; RA, rim area; CDAR, cup-to-disc area ratio; HVC, height variation contour; CSM, cup shape measure; TS, temporal superior; TI, temporal inferior; NS, nasal superior; NI, nasal inferior.

###### 

ROC, sensitivity, and specificity for the FSM discriminant function, MRA, and GPS used to discriminate between normal eyes and eyes with SSOH

                          ROC                                    Sensitivity          Specificity
  ----------------------- ---------------------- --------------- -------------------- --------------------
  FSM                     0.976 (0.826--0.990)                   92.3 (63.9--98.7)%   92.3 (63.9--98.7)%
  MRA overall             0.914 (0.736--0.986)   BL = abnormal   84.6 (54.5--97.6)%   92.3 (63.9--98.7)%
                                                 BL = normal     76.9 (46.2--94.7)%   100 (75.1--100)%
  MRA global              0.885 (0.698--0.974)   BL = abnormal   76.9 (46.2--94.7)%   100 (75.1--100)%
                                                 BL = normal     76.9 (46.2--94.7)%   100 (75.1--100)%
  MRA temporal            0.538 (0.334--0.734)   BL = abnormal   7.7 (1.3--36.1)%     100 (75.1--100)%
                                                 BL = normal     0.0 (0.0--24.9)%     100 (75.1--100)%
  MRA temporal superior   0.654 (0.443--0.828)   BL = abnormal   30.8 (9.3--61.4)%    100 (75.1--100)%
                                                 BL = normal     30.8 (9.3--61.4)%    100 (75.1--100)%
  MRA temporal inferior   0.615 (0.406--0.797)   BL = abnormal   23.1 (5.3--53.8)%    100 (75.1--100)%
                                                 BL = normal     23.1 (5.3--53.8)%    100 (75.1--100)%
  MRA nasal               0.846 (0.651--0.955)   BL = abnormal   69.2 (38.6--90.7)%   100 (75.1--100)%
                                                 BL = normal     69.2 (38.6--90.7)%   100 (75.1--100)%
  MRA nasal superior      0.956 (0.794--0.994)   BL = abnormal   92.3 (63.9--98.7)%   92.3 (63.9--98.7)%
                                                 BL = normal     84.6 (54.5--97.6)%   100 (75.1--100)%
  MRA nasal inferior      0.654 (0.443--0.828)   BL = abnormal   30.8 (9.3--61.4)%    100 (75.1--100)%
                                                 BL = normal     30.8 (9.3--61.4)%    100 (75.1--100)%
  GPS overall             0.710 (0.500--0.869)   BL = abnormal   46.2 (19.3--74.8)%   92.3 (63.9--98.7)%
                                                 BL = normal     46.2 (19.3--74.8)%   100 (75.1--100)%
  GPS global              0.731 (0.522--0.884)   BL = abnormal   46.2 (19.3--74.8)%   100 (75.1--100)%
                                                 BL = normal     46.2 (19.3--74.8)%   100 (75.1--100)%
  GPS temporal            0.727 (0.509--0.886)   BL = abnormal   45.5 (16.9--76.5)%   100 (75.1--100)%
                                                 BL = normal     45.5 (16.9--76.5)%   100 (75.1--100)%
  GPS temporal superior   0.706 (0.48--0.872)    BL = abnormal   45.5 (16.9--76.5)%   92.3 (63.9--98.7)%
                                                 BL = normal     45.5 (16.9--76.5)%   100 (75.1--100)%
  GPS temporal inferior   0.727 (0.509--0.886)   BL = abnormal   45.5 (16.9--76.5)%   100 (75.1--100)%
                                                 BL = normal     45.5 (16.9--76.5)%   100 (75.1--100)%
  GPS nasal               0.727 (0.509--0.886)   BL = abnormal   45.5 (16.9--76.5)%   100 (75.1--100)%
                                                 BL = normal     45.5 (16.9--76.5)%   100 (75.1--100)%
  GPS nasal superior      0.727 (0.509--0.886)   BL = abnormal   45.5 (16.9--76.5)%   100 (75.1--100)%
                                                 BL = normal     45.5 (16.9--76.5)%   100 (75.1--100)%
  GPS nasal inferior      0.727 (0.509--0.886)   BL = abnormal   45.5 (16.9--76.5)%   100 (75.1--100)%
                                                 BL = normal     45.5 (16.9--76.5)%   100 (75.1--100)%

**Note:** Data are expressed with 95% confidence intervals of each value in the parentheses.

**Abbreviations:** FSM, FSM classification; MRA, Moorfield regression analysis; GPS, glaucoma probability score; "BL = abnormal", when the borderline is regarded as abnormal; "BL = normal", when the borderline is regarded as normal; ROC, receiver operating characteristic; SSOH; superior segmental optic hypoplasia.
